Innosurge Biologics A/S

CVR 38768964 · Public limited company (A/S) · Active · Low risk

Innosurge Biologics A/S is a Public limited company (A/S), founded on , based in Randers NV. The company is registered in the industry engroshandel med læge- og hospitalsartikler. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 9 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.9m and a net result of DKK 1.7m.

Bankruptcy risk for Innosurge Biologics A/S

0.2%
probability of bankruptcy within 12 months
Low risk

0.2 × the average (1.41%) · higher risk than 49% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of CEOs0 · bankruptcy rate 12.7%1.4×
CEO changes1 · bankruptcy rate 11.4%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Company typeA/S · bankruptcy rate 4.4%0.50×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
38768964
Status
Active
Company type
Public limited company (A/S)
Founded
(9 years)
Address
Alsikevej 16
8920 Randers NV
Municipality
Randers
Industry
Engroshandel med læge- og hospitalsartikler (464620)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 500k
Employees
1 (2018)
Auditor
Grant Thornton, Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 9
Missing annual reportNo
Negative equityNo
Equity ratio51.1%
Current ratio131%
Moves (last 2 years)0
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address19
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK 4.5mDKK 2.4mDKK 2.1m
Net profitDKK 1.7mDKK 252kDKK 407k
EquityDKK 2.9mDKK 2.0mDKK 1.7m
Total assetsDKK 5.7mDKK 3.6mDKK 4.7m
CashDKK 558kDKK 1.2m–
Short-term debtDKK 2.8mDKK 1.6m–
Avg. employees22–

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Grant Thornton, Godkendt Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025173
1 Jan 2024 – 31 Dec 2024180
1 Jan 2023 – 31 Dec 2023176
1 Jan 2022 – 31 Dec 2022179
1 Jan 2021 – 31 Dec 2021124
1 Jan 2020 – 31 Dec 2020165
1 Jan 2019 – 31 Dec 2019134
1 Jan 2018 – 31 Dec 2018128
23 Jun 2017 – 31 Dec 2017101

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOPeter Møller Lassen
BoardMichael Maigaard NielsenCurrent
BoardPeter Møller LassenCurrent
BoardHeinz Kvottrup LorentzenCurrent
BoardHeinz Kvottrup Lorentzen
BoardSvend Aage Jensen
BoardHeinz Kvottrup Lorentzen
Owner (100%)CMA HOLDING RANDERS ApSCurrent
AuditorGrant Thornton, Godkendt RevisionspartnerselskabCurrent
AuditorKvist & Jensen Statsautoriseret Revisionspartnerselskab
FounderCMA HOLDING RANDERS ApSCurrent

The CEOs' other companies

Peter Møller Lassen – 33 other companies, of which 4 bankrupt

Address history (1 moves)

Alsikevej 16, 8920 Randers NV
Alsikevej 16, 8920 Randers NV

Employees per year

Number of employees at Innosurge Biologics A/S per year112017: 120172018: 12018

Other companies at the same address

Similar companies in Randers

Questions and answers about Innosurge Biologics A/S

Has Innosurge Biologics A/S gone bankrupt?

No, Innosurge Biologics A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Innosurge Biologics A/S?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.

Who is the auditor of Innosurge Biologics A/S?

Innosurge Biologics A/S most recently used Grant Thornton, Godkendt Revisionspartnerselskab.

When was Innosurge Biologics A/S founded?

Innosurge Biologics A/S was founded on 23 June 2017.

What is the equity of Innosurge Biologics A/S?

Equity was DKK 2.9m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.